Gaining Efficiency in Clinical Trials With Cardiac Biomarkers

被引:8
|
作者
Januzzi, James L., Jr. [1 ,2 ]
Canty, John M. [3 ,4 ]
Das, Saumya [1 ]
DeFilippi, Christopher R. [5 ]
Gintant, Gary A. [6 ]
Gutstein, David E. [7 ]
Jaffe, Allan [8 ,9 ]
Kaushik, Emily P. [10 ]
Leptak, Christopher [11 ]
Mehta, Cyrus [12 ,13 ]
Pina, Ileana [14 ]
Povsic, Thomas J. [15 ,16 ]
Rambaran, Curtis [17 ]
Rhyne, Rhonda F. [18 ]
Salas, Maribel [17 ,19 ]
Shi, Victor C. [20 ]
Udell, Jacob A. [21 ,22 ]
Unger, Ellis F. [23 ]
Zabka, Tanja S. [24 ]
Seltzer, Jonathan H. [25 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02115 USA
[2] Baim Inst Clin Res, Boston, MA USA
[3] Univ Buffalo, Div Cardiovasc Med, Buffalo, NY USA
[4] Western New York Hlth Care Syst, Dept Vet Affairs, Buffalo, NY USA
[5] Inova Heart & Vasc Inst, Falls Church, VA USA
[6] AbbVie Pharmaceut, Dept Integrat Pharmacol Integrated Sci & Technol, Cambridge, MA USA
[7] Janssen Pharmaceut, Cardiovasc Metab Discovery, Titusville, NJ USA
[8] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[9] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
[10] Takeda Pharmaceut, Global Drug Safety Res & Evaluat, Boston, MA USA
[11] US FDA, Biomarker Qualificat Program, Off New Drugs, Ctr Drug Dev & Res, Silver Spring, MD USA
[12] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[13] Cytel Inc, Boston, MA USA
[14] Wayne State Univ, Detroit, MI USA
[15] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[16] Duke Univ, Dept Med, Durham, NC USA
[17] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[18] Prevencio Inc, Kirkland, WA USA
[19] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[20] Novartis Pharmaceut, Basel, Switzerland
[21] Univ Toronto, Womens Coll Hosp, Cardiovasc Div, Toronto, ON, Canada
[22] Univ Toronto, Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto, ON, Canada
[23] US FDA, Off Cardiol Hematol Endocrinol & Nephrol, Off New Drugs, Ctr Drug Dev & Res, Silver Spring, MD USA
[24] Genentech Inc, Dev Sci Safety Assessment, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
[25] WCG Clin & WCG ACI Clin, Bala Cynwood, PA USA
关键词
biomarker; clinical trials; biobanking; ROSUVASTATIN MULTINATIONAL TRIAL; BRAIN NATRIURETIC PEPTIDE; SAMPLED BLOOD ARCHIVE; HEART-FAILURE; CORONARY; THERAPY; ANGIOGRAPHY; PREDICTION; SURVIVAL; BENEFIT;
D O I
10.1016/j.jacc.2021.02.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The momentum of cardiovascular drug development has slowed dramatically. Use of validated cardiac biomarkers in clinical trials could accelerate development of much-needed therapies, but biomarkers have been used less for cardiovascular drug development than in therapeutic areas such as oncology. Moreover, there are inconsistences in biomarker use in clinical trials, such as sample type, collection times, analytical methods, and storage for future research. With these needs in mind, participants in a Cardiac Safety Research Consortium Think Tank proposed the development of international guidance in this area, together with improved quality assurance and analytical methods, to determine what biomarkers can reliably show. Participants recommended the development of systematic methods for sample collection, and the archiving of samples in all cardiovascular clinical trials (including creation of a biobank or repository). The academic and regulatory communities also agreed to work together to ensure that published information is fully and clearly expressed.
引用
收藏
页码:1922 / 1933
页数:12
相关论文
共 50 条
  • [41] Improving the efficiency of clinical trials in multiple sclerosis
    Marrie, Ruth Ann
    Sormani, Maria Pia
    Mangion, Sean Apap
    Bovis, Francesca
    Cheung, Winson Y.
    Cutter, Gary R.
    Feys, Peter
    Hill, Michael D.
    Koch, Marcus Werner
    McCreary, Morgan
    Mowry, Ellen M.
    Park, Jay J. H.
    Piehl, Fredrik
    Salter, Amber
    Chataway, Jeremy
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (09) : 1136 - 1148
  • [42] Bayesian statistics and the efficiency and ethics of clinical trials
    Berry, DA
    STATISTICAL SCIENCE, 2004, 19 (01) : 175 - 187
  • [43] Multimodal Evoked Potentials as Candidate Prognostic and Response Biomarkers in Clinical Trials of Multiple Sclerosis
    Hardmeier, Martin
    Fuhr, Peter
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2021, 38 (03) : 171 - 180
  • [44] Endpoints in oncology clinical trials
    Kilickap, Saadettin
    Demirci, Umut
    Karadurmus, Nuri
    Dogan, Mutlu
    Akinci, Bulent
    Sendur, Mehmet Ali Nahit
    JOURNAL OF BUON, 2018, 23 : S1 - S6
  • [45] Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
    Morel, Alix
    Lebard, Pierre
    Dereux, Alexandra
    Azuar, Julien
    Questel, Frank
    Bellivier, Frank
    Marie-Claire, Cynthia
    Fatseas, Melina
    Vorspan, Florence
    Bloch, Vanessa
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [46] The Future of Cardiac Magnetic Resonance Clinical Trials
    Rabbat, Mark G.
    Kwong, Raymond Y.
    Heitner, John F.
    Young, Alistair A.
    Shanbhag, Sujata M.
    Petersen, Steffen E.
    Selvanayagam, Joseph B.
    Berry, Colin
    Nagel, Eike
    Heydari, Bobak
    Maceira, Alicia M.
    Shenoy, Chetan
    Dyke, Christopher
    Bilchick, Kenneth C.
    JACC-CARDIOVASCULAR IMAGING, 2022, 15 (12) : 2127 - 2138
  • [47] Cardiac biomarkers for risk stratification of arrhythmic death in patients with heart failure and reduced ejection fraction
    Burger, A. L.
    Stojkovic, S.
    Diedrich, A.
    Wojta, J.
    Demyanets, S.
    Pezawas, T.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2021, 78 (04) : 195 - 200
  • [48] Current Use of Cardiac Biomarkers in Various Heart Conditions
    Khan, Shahzad
    Rasool, Sahibzada T.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (06) : 980 - 993
  • [49] Biomarkers of ALI/ARDS: Pathogenesis, Discovery, and Relevance to Clinical Trials
    Janz, David R.
    Ware, Lorraine B.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (04) : 537 - 547
  • [50] A Review of Clinical Trials in Spinal Cord Injury Including Biomarkers
    Badhiwala, Jetan H.
    Wilson, Jefferson R.
    Kwon, Brian K.
    Casha, Steven
    Fehlings, Michael G.
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : 1906 - 1917